Description Nuclera is a venture-backed, founder-driven biotech company headquartered in Cambridge, UK with significant operations in Boston, USA. The company’s mission is to make biology accessible to everyone through desktop bioprinting. We are beginning this mission by making proteins accessible through the launch and on-going development of our eProtein desktop bioprinting platform. eProtein promises to be a breakthrough protein expression, characterization and purification technology that brings rapid prototyping to the life science benchtop and accelerates the drug discovery process. Nuclera is entering the next phase of its growth with plans to dramatically expand its staff over the next 12-24 months offering extensive learning and career progression opportunities. We are seeking an experienced and ambitious Applications Specialist to help with customer deployments, technical problem solving and eventually support building up the global FAS team. This role will initially require some travel to the UK for initial training and meeting the wider UK teams, before supporting the US customer base and operations. This will allow you to develop a strong understanding of our technology, its current and future capabilities and the applications this can be applied to in user laboratories. You will be the key person demonstrating our platform to customers and will be their primary contact for technical discussions. This role will suit an individual who has experience and drive working in a fast-paced biotech environment with a track record of execution and teamwork. You should be well versed with Proteins Science to be able to understand customer requirements and competently demonstrate Nuclera’s value to fit customer workflows. About the role Requirements Essential Desirable Benefits What we offer: In addition to competitive salaries, we offer a range of benefits including: Car allowance and travel expenses when traveling for direct customer support standards to an FAS role.
Field Application Scientist (UK)
Application Instructions:
Application Closing Date:
30 April 2024